Europe Cell Therapy Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Cell Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Cell Therapy Market Segmentations:

    By Player:

    • Athersys

    • Mesoblast

    • Celgene

    • Cell Medica

    • Bio-Tissue

    • Astellas Pharma

    • Anterogen

    • BIOCELLULAR THERAPIES

    • Biogen Idec

    • BioCardia

    • BioTissue Technologies

    • BrainStorm Cell Therapeutics

    • CellBioMed

    • Bone Therapeutics

    • AlloCure

    • Caladrius

    • BIOTIME

    • AxoGen

    • Avita Medical

    • Vericel

    • Antibe Therapeutics

    • Amorcyte

    • Capricor Therapeutics

    • Bellicum Pharmaceuticals

    • Dendreon

    • Bluebird Bio

    By Type:

    • Nanotechnology

    • Natural Substances

    By End-User:

    • Scientific Research

    • Hospital

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cell Therapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Cell Therapy Market Size and Growth Rate of Nanotechnology from 2014 to 2026

    • 1.3.2 Europe Cell Therapy Market Size and Growth Rate of Natural Substances from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Cell Therapy Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • 1.4.2 Europe Cell Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Europe Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cell Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Nanotechnology

      • 3.4.2 Market Size and Growth Rate of Natural Substances

    4 Segmentation of Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cell Therapy for Scientific Research

      • 4.4.2 Market Size and Growth Rate of Cell Therapy for Hospital

      • 4.4.3 Market Size and Growth Rate of Cell Therapy for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Cell Therapy Production Analysis by Top Regions

    • 5.2 Europe Cell Therapy Consumption Analysis by Top Regions

    • 5.3 Europe Cell Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 France Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of Cell Therapy Market among Top Countries

    • 6.1 Top 5 Export Countries in Cell Therapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Cell Therapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Cell Therapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cell Therapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Cell Therapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Cell Therapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Cell Therapy Landscape Analysis

    • 7.1 Germany Cell Therapy Landscape Analysis by Major Types

    • 7.2 Germany Cell Therapy Landscape Analysis by Major End-Users

    8. UK Cell Therapy Landscape Analysis

    • 8.1 UK Cell Therapy Landscape Analysis by Major Types

    • 8.2 UK Cell Therapy Landscape Analysis by Major End-Users

    9. France Cell Therapy Landscape Analysis

    • 9.1 France Cell Therapy Landscape Analysis by Major Types

    • 9.2 France Cell Therapy Landscape Analysis by Major End-Users

    10. Italy Cell Therapy Landscape Analysis

    • 10.1 Italy Cell Therapy Landscape Analysis by Major Types

    • 10.2 Italy Cell Therapy Landscape Analysis by Major End-Users

    11. Spain Cell Therapy Landscape Analysis

    • 11.1 Spain Cell Therapy Landscape Analysis by Major Types

    • 11.2 Spain Cell Therapy Landscape Analysis by Major End-Users

    12. Poland Cell Therapy Landscape Analysis

    • 12.1 Poland Cell Therapy Landscape Analysis by Major Types

    • 12.2 Poland Cell Therapy Landscape Analysis by Major End-Users

    13. Russia Cell Therapy Landscape Analysis

    • 13.1 Russia Cell Therapy Landscape Analysis by Major Types

    • 13.2 Russia Cell Therapy Landscape Analysis by Major End-Users

    14. Switzerland Cell Therapy Landscape Analysis

    • 14.1 Switzerland Cell Therapy Landscape Analysis by Major Types

    • 14.2 Switzerland Cell Therapy Landscape Analysis by Major End-Users

    15. Turkey Cell Therapy Landscape Analysis

    • 15.1 Turkey Cell Therapy Landscape Analysis by Major Types

    • 15.2 Turkey Cell Therapy Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis by Top Countries

      • 16.3.1 Denmark Cell Therapy Market Volume and Growth Rate

      • 16.3.2 Finland Cell Therapy Market Volume and Growth Rate

      • 16.3.3 Norway Cell Therapy Market Volume and Growth Rate

      • 16.3.4 Sweden Cell Therapy Market Volume and Growth Rate

      • 16.3.6 Iceland Cell Therapy Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis by Top Countries

      • 17.3.1 Belgium Cell Therapy Market Volume and Growth Rate

      • 17.3.2 Netherlands Cell Therapy Market Volume and Growth Rate

      • 17.3.3 Luxembourg Cell Therapy Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis by Top Countries

      • 18.3.1 Estonia Cell Therapy Market Volume and Growth Rate

      • 18.3.2 Latvia Cell Therapy Market Volume and Growth Rate

      • 18.3.3 Lithuania Cell Therapy Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Athersys

      • 19.1.1 Athersys Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Mesoblast

      • 19.2.1 Mesoblast Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Celgene

      • 19.3.1 Celgene Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Cell Medica

      • 19.4.1 Cell Medica Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Bio-Tissue

      • 19.5.1 Bio-Tissue Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Astellas Pharma

      • 19.6.1 Astellas Pharma Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Anterogen

      • 19.7.1 Anterogen Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 BIOCELLULAR THERAPIES

      • 19.8.1 BIOCELLULAR THERAPIES Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Biogen Idec

      • 19.9.1 Biogen Idec Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 BioCardia

      • 19.10.1 BioCardia Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 BioTissue Technologies

      • 19.11.1 BioTissue Technologies Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 BrainStorm Cell Therapeutics

      • 19.12.1 BrainStorm Cell Therapeutics Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 CellBioMed

      • 19.13.1 CellBioMed Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Bone Therapeutics

      • 19.14.1 Bone Therapeutics Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 AlloCure

      • 19.15.1 AlloCure Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Caladrius

      • 19.16.1 Caladrius Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 BIOTIME

      • 19.17.1 BIOTIME Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 AxoGen

      • 19.18.1 AxoGen Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Avita Medical

      • 19.19.1 Avita Medical Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Vericel

      • 19.20.1 Vericel Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Antibe Therapeutics

      • 19.21.1 Antibe Therapeutics Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Amorcyte

      • 19.22.1 Amorcyte Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Capricor Therapeutics

      • 19.23.1 Capricor Therapeutics Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Bellicum Pharmaceuticals

      • 19.24.1 Bellicum Pharmaceuticals Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Dendreon

      • 19.25.1 Dendreon Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Bluebird Bio

      • 19.26.1 Bluebird Bio Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    The List of Tables and Figures (Totals 77 Figures and 110 Tables)

    • Figure Product Picture

    • Figure Europe Cell Therapy Market Size and Growth Rate of Nanotechnology from 2014 to 2026

    • Figure Europe Cell Therapy Market Size and Growth Rate of Natural Substances from 2014 to 2026

    • Figure Europe Cell Therapy Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Europe Cell Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure France Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cell Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cell Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of Cell Therapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Nanotechnology

    • Figure Market Size and Growth Rate of Natural Substances

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cell Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cell Therapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Scientific Research

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Others

    • Table Europe Cell Therapy Production by Major Regions

    • Table Europe Cell Therapy Production Share by Major Regions

    • Figure Europe Cell Therapy Production Share by Major Countries and Regions in 2014

    • Table Europe Cell Therapy Consumption by Major Regions

    • Table Europe Cell Therapy Consumption Share by Major Regions

    • Table Germany Cell Therapy Production, Import, Consumption and Export Analysis

    • Table UK Cell Therapy Production, Import, Consumption and Export Analysis

    • Table France Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Italy Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Spain Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Poland Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Russia Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Switzerland Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Turkey Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cell Therapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cell Therapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Cell Therapy Consumption by Types from 2014 to 2026

    • Table Germany Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Germany Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Germany Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table UK Cell Therapy Consumption by Types from 2014 to 2026

    • Table UK Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table UK Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table UK Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table France Cell Therapy Consumption by Types from 2014 to 2026

    • Table France Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table France Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table France Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Italy Cell Therapy Consumption by Types from 2014 to 2026

    • Table Italy Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Italy Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Italy Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Spain Cell Therapy Consumption by Types from 2014 to 2026

    • Table Spain Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Spain Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Spain Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Poland Cell Therapy Consumption by Types from 2014 to 2026

    • Table Poland Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Poland Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Poland Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Russia Cell Therapy Consumption by Types from 2014 to 2026

    • Table Russia Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Russia Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Russia Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption by Types from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Cell Therapy Consumption by Types from 2014 to 2026

    • Table Turkey Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Turkey Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Turkey Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Athersys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Athersys

    • Figure Sales and Growth Rate Analysis of Athersys

    • Figure Revenue and Market Share Analysis of Athersys

    • Table Product and Service Introduction of Athersys

    • Table Company Profile and Development Status of Mesoblast

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mesoblast

    • Figure Sales and Growth Rate Analysis of Mesoblast

    • Figure Revenue and Market Share Analysis of Mesoblast

    • Table Product and Service Introduction of Mesoblast

    • Table Company Profile and Development Status of Celgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

    • Figure Sales and Growth Rate Analysis of Celgene

    • Figure Revenue and Market Share Analysis of Celgene

    • Table Product and Service Introduction of Celgene

    • Table Company Profile and Development Status of Cell Medica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Medica

    • Figure Sales and Growth Rate Analysis of Cell Medica

    • Figure Revenue and Market Share Analysis of Cell Medica

    • Table Product and Service Introduction of Cell Medica

    • Table Company Profile and Development Status of Bio-Tissue

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Tissue

    • Figure Sales and Growth Rate Analysis of Bio-Tissue

    • Figure Revenue and Market Share Analysis of Bio-Tissue

    • Table Product and Service Introduction of Bio-Tissue

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Anterogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anterogen

    • Figure Sales and Growth Rate Analysis of Anterogen

    • Figure Revenue and Market Share Analysis of Anterogen

    • Table Product and Service Introduction of Anterogen

    • Table Company Profile and Development Status of BIOCELLULAR THERAPIES

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCELLULAR THERAPIES

    • Figure Sales and Growth Rate Analysis of BIOCELLULAR THERAPIES

    • Figure Revenue and Market Share Analysis of BIOCELLULAR THERAPIES

    • Table Product and Service Introduction of BIOCELLULAR THERAPIES

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of BioCardia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCardia

    • Figure Sales and Growth Rate Analysis of BioCardia

    • Figure Revenue and Market Share Analysis of BioCardia

    • Table Product and Service Introduction of BioCardia

    • Table Company Profile and Development Status of BioTissue Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTissue Technologies

    • Figure Sales and Growth Rate Analysis of BioTissue Technologies

    • Figure Revenue and Market Share Analysis of BioTissue Technologies

    • Table Product and Service Introduction of BioTissue Technologies

    • Table Company Profile and Development Status of BrainStorm Cell Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BrainStorm Cell Therapeutics

    • Figure Sales and Growth Rate Analysis of BrainStorm Cell Therapeutics

    • Figure Revenue and Market Share Analysis of BrainStorm Cell Therapeutics

    • Table Product and Service Introduction of BrainStorm Cell Therapeutics

    • Table Company Profile and Development Status of CellBioMed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CellBioMed

    • Figure Sales and Growth Rate Analysis of CellBioMed

    • Figure Revenue and Market Share Analysis of CellBioMed

    • Table Product and Service Introduction of CellBioMed

    • Table Company Profile and Development Status of Bone Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bone Therapeutics

    • Figure Sales and Growth Rate Analysis of Bone Therapeutics

    • Figure Revenue and Market Share Analysis of Bone Therapeutics

    • Table Product and Service Introduction of Bone Therapeutics

    • Table Company Profile and Development Status of AlloCure

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AlloCure

    • Figure Sales and Growth Rate Analysis of AlloCure

    • Figure Revenue and Market Share Analysis of AlloCure

    • Table Product and Service Introduction of AlloCure

    • Table Company Profile and Development Status of Caladrius

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Caladrius

    • Figure Sales and Growth Rate Analysis of Caladrius

    • Figure Revenue and Market Share Analysis of Caladrius

    • Table Product and Service Introduction of Caladrius

    • Table Company Profile and Development Status of BIOTIME

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOTIME

    • Figure Sales and Growth Rate Analysis of BIOTIME

    • Figure Revenue and Market Share Analysis of BIOTIME

    • Table Product and Service Introduction of BIOTIME

    • Table Company Profile and Development Status of AxoGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AxoGen

    • Figure Sales and Growth Rate Analysis of AxoGen

    • Figure Revenue and Market Share Analysis of AxoGen

    • Table Product and Service Introduction of AxoGen

    • Table Company Profile and Development Status of Avita Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avita Medical

    • Figure Sales and Growth Rate Analysis of Avita Medical

    • Figure Revenue and Market Share Analysis of Avita Medical

    • Table Product and Service Introduction of Avita Medical

    • Table Company Profile and Development Status of Vericel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vericel

    • Figure Sales and Growth Rate Analysis of Vericel

    • Figure Revenue and Market Share Analysis of Vericel

    • Table Product and Service Introduction of Vericel

    • Table Company Profile and Development Status of Antibe Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antibe Therapeutics

    • Figure Sales and Growth Rate Analysis of Antibe Therapeutics

    • Figure Revenue and Market Share Analysis of Antibe Therapeutics

    • Table Product and Service Introduction of Antibe Therapeutics

    • Table Company Profile and Development Status of Amorcyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amorcyte

    • Figure Sales and Growth Rate Analysis of Amorcyte

    • Figure Revenue and Market Share Analysis of Amorcyte

    • Table Product and Service Introduction of Amorcyte

    • Table Company Profile and Development Status of Capricor Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Capricor Therapeutics

    • Figure Sales and Growth Rate Analysis of Capricor Therapeutics

    • Figure Revenue and Market Share Analysis of Capricor Therapeutics

    • Table Product and Service Introduction of Capricor Therapeutics

    • Table Company Profile and Development Status of Bellicum Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bellicum Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Bellicum Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Bellicum Pharmaceuticals

    • Table Product and Service Introduction of Bellicum Pharmaceuticals

    • Table Company Profile and Development Status of Dendreon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon

    • Figure Sales and Growth Rate Analysis of Dendreon

    • Figure Revenue and Market Share Analysis of Dendreon

    • Table Product and Service Introduction of Dendreon

    • Table Company Profile and Development Status of Bluebird Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio

    • Figure Sales and Growth Rate Analysis of Bluebird Bio

    • Figure Revenue and Market Share Analysis of Bluebird Bio

    • Table Product and Service Introduction of Bluebird Bio

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.